Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;14(8):689-694.
doi: 10.1111/crj.13185. Epub 2020 Mar 31.

Is Onodera's prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?

Affiliations

Is Onodera's prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?

Derya Yenibertiz et al. Clin Respir J. 2020 Aug.

Abstract

Introduction: We aimed to evaluate the prognostic value of Onodera's prognostic nutritional index (OPNI) in patients with Small-cell lung cancer (SCLC).

Materials and methods: This study retrospectively examined 109 patients diagnosed with SCLC between January 2008 and October 2018 in our hospital. Patients were divided into two groups according to the median of OPNI values.

Results: A significant difference was observed between the groups in terms of neutrophil percentage, lymphocyte count, lymphocyte percentage, C-reactive protein (CRP), albumin, lactat dehidrogenase (LDH) and neutrophil to lymphocyte ratio (NLR) (P < 0.05). LDH, CRP, neutrophil percentage and NLR (P = 0.008, P < 0.001, P = 0.001, P < 0.001, respectively) were significantly higher and albumin, lymphocyte count and lymphocyte percentage (P < 0.001, P < 0.001, P = 0.001, respectively) were significantly lower in the low OPNI group. Survival analyses have shown that mortality rates and lifespan are similar in the two groups.

Conclusion: The OPNI may be a helpful tool for determining the prognosis in SCLC.

Keywords: prognosis; small cell lung cancer; the Onodera’s prognostic nutritional index (OPNI).

PubMed Disclaimer

References

REFERENCES

    1. Govindan R, Page N , Morgensztern D , et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24:4539-4544.
    1. Shepherd FA , Crowley J , Van Houtte P , et al. The international association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2007;2:1067-1077.
    1. Sabari JK , Lok BH , Laird JH , Poirier JT , Rudin CM . Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. September 2017;14(9):549-561.
    1. Cao S , Jin S , Shen J , et al. Selected patients can benefit more from the management of etoposide and platinum based chemotherapy and thoracic irradiation a retrospective analysis of 707 small cell lung cancer patients. Oncotarget. 2017;8:8657-8669.
    1. Onodera T , Goseki N , Kosaki G . Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001-1005.

LinkOut - more resources